Status:
UNKNOWN
Role of T Helper 17 and Regulatory T Cells in Delayed Graft Function
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborating Sponsors:
Astellas Pharma Canada, Inc.
Conditions:
Delayed Graft Function
Eligibility:
All Genders
18+ years
Brief Summary
Delayed graft function (DGF) increases risk of acute rejection after kidney transplantation (KTx). Interleukin-6, which is produced in DGF, is critical in directing naive T helper cells differentiatio...
Detailed Description
All adult recipients of a primary kidney transplant will be eligible. Subjects will have blood samples drawn from which we will isolate lymphocytes and analyze the Treg population based on surface mar...
Eligibility Criteria
Inclusion
- Kidney transplant recipients
Exclusion
- None
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01232816
Start Date
July 1 2010
End Date
December 1 2019
Last Update
September 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Center
Montreal, Quebec, Canada, H3A 1A1